Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma
Sponsor: Erasmus Medical Center
Summary
A multicentre randomised controlled trial (RCT) will be conducted to evaluate the effectiveness of the digital personalised Melanoma Survivorship Care Plan (SCP) app. A total of hundred-eighty melanoma patients (stage I and II) will be randomised to receive either the SCP Melanoma app or usual care. The app provides survivors with personalized healthcare information on diagnosis, treatment and follow-up and supportive care, tailored to their melanoma stage and phase and information needs.Through questionnaires, medical file records, patient-reported outcomes and use of medical care will be evaluated. In addition, log-data, questionnaires and interviews will be used to evaluate the process of the uptake and implementation of the digital SCP.
Official title: Personalised Survivorship Care for Patients With Melanoma: A Multicenter Randomised Controlled Trial of the Survivorship Care Plan App
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2025-04-01
Completion Date
2026-12-01
Last Updated
2025-06-11
Healthy Volunteers
No
Interventions
Digizorg Melanoma app
The Digizorg Melanoma app is a digital survivorship care plan, in which ellaborated information regarding diagnosis, treatment and follow-up and supportive care, adjusted to one's personal preferences and disease characteristics, is offered in the form of a mobile application.
Locations (4)
Albert Schweitzer hospital
Dordrecht, South Holland, Netherlands
Erasmus MC
Rotterdam, South Holland, Netherlands
Franciscus Gasthuis & Vlietland hospital
Rotterdam, South Holland, Netherlands
Maasstad hospital
Rotterdam, South Holland, Netherlands